Core Laboratories (NYSE:CLB) Issues Q3 2025 Earnings Guidance

Core Laboratories (NYSE:CLB - Get Free Report) updated its third quarter 2025 earnings guidance on Wednesday. The company provided earnings per share guidance of 0.180-0.220 for the period, compared to the consensus earnings per share estimate of 0.220. The company issued revenue guidance of $127.5 million-$134.5 million, compared to the consensus revenue estimate of $129.6 million.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on CLB shares. Wall Street Zen cut shares of Core Laboratories from a "hold" rating to a "sell" rating in a research note on Friday, April 25th. Citigroup lowered their price target on Core Laboratories from $16.00 to $13.00 and set a "neutral" rating for the company in a research report on Tuesday, May 13th. Finally, Stifel Nicolaus cut their price target on Core Laboratories from $13.00 to $12.00 and set a "hold" rating on the stock in a research note on Wednesday, July 16th.

Core Laboratories Trading Down 12.2%

Shares of NYSE CLB traded down $1.63 during mid-day trading on Friday, reaching $11.73. 815,069 shares of the company's stock were exchanged, compared to its average volume of 455,720. The company's 50-day moving average is $11.84 and its 200-day moving average is $13.94. Core Laboratories has a 52-week low of $10.14 and a 52-week high of $25.13. The firm has a market capitalization of $549.71 million, a price-to-earnings ratio of 18.91, a PEG ratio of 3.88 and a beta of 1.41. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.64 and a current ratio of 2.21.

Core Laboratories (NYSE:CLB - Get Free Report) last issued its earnings results on Wednesday, July 23rd. The oil and gas company reported $0.19 earnings per share for the quarter, topping the consensus estimate of $0.18 by $0.01. The business had revenue of $130.16 million for the quarter, compared to analyst estimates of $129.19 million. Core Laboratories had a return on equity of 14.28% and a net margin of 5.73%. The business's quarterly revenue was down .3% on a year-over-year basis. During the same quarter last year, the company earned $0.22 EPS. Analysts expect that Core Laboratories will post 0.96 EPS for the current fiscal year.

Core Laboratories Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, August 25th. Stockholders of record on Monday, August 4th will be issued a $0.01 dividend. The ex-dividend date of this dividend is Monday, August 4th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.34%. Core Laboratories's dividend payout ratio is presently 6.78%.

Institutional Trading of Core Laboratories

An institutional investor recently raised its position in Core Laboratories stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 4.4% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 27,893 shares of the oil and gas company's stock after purchasing an additional 1,170 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. owned 0.06% of Core Laboratories worth $418,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 97.81% of the company's stock.

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.